Screener
HEAL vs XPH
Global X HealthTech ETF vs State Street SPDR S&P Pharmaceuticals ETF
Key differences
- XPH costs 0.15% less per year.
- XPH is significantly larger than HEAL — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, XPH has delivered higher annualized returns.
- XPH has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| HEAL | XPH | |
|---|---|---|
| Annual cost (TER) | 0.50% | 0.35% |
| Fund size (AUM) | $25M | $355M |
| Since | 2020 | 2006 |
| Dividend yield | 0.38% | 0.65% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | -20.2% | +46.3% |
| CAGR 3Y | -10.3% | +13.8% |
| CAGR 5Y | -14.0% | +4.5% |
| Sharpe 3Y | -0.46 | 0.57 |
| Volatility 1Y | 21.71% | 21.29% |
| Max drawdown | -65.76% | -35.96% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to HEAL and XPH
Explore further